
Why we should treat caffeine like the brain-altering drug it is
Like billions of people, I use caffeine. But there is a glaring double standard in the drugs we stigmatise or celebrate
by Jonathan Simone
Adjunct Professor of Neuroscience and Biological Sciences, Brock University, Canada
Jonathan Simone is vice president of research and analytics at Kleinburg Private Wealth, a financial advisor at Carte Wealth Management, and an adjunct professor of biological sciences at Brock University in Canada, where he specialises in the areas of neurodevelopment and neuropharmacology.